The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis

The novel coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a global challenge. Currently, there is some information on the consequences of COVID-19 infection in multiple sclerosis (MS) patients, as it is a newly discovered...

Descripción completa

Detalles Bibliográficos
Autores principales: Dziedzic, Angela, Saluk-Bijak, Joanna, Miller, Elzbieta, Niemcewicz, Marcin, Bijak, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918534/
https://www.ncbi.nlm.nih.gov/pubmed/33670394
http://dx.doi.org/10.3390/ijms22041804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918534/
https://www.ncbi.nlm.nih.gov/pubmed/33670394
http://dx.doi.org/10.3390/ijms22041804

Ejemplares similares